EUVIMEDEUVIMED entdecken
Crossref

Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs

Ludmila P Gargano, Juliana Alvares-Teodoro, Francisco de A Acurcio, Augusto A Guerra

Expert Review of Pharmacoeconomics & Outcomes Research · 2024

DOI: 10.1080/14737167.2024.2365985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2024. Verfasst von Ludmila P Gargano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Medicines and Pharmaceutical Care (PPGMAF), Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte…. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Antineoplastic Agents, Research Design, Algorithms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Minas Gerais State Research Support Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We propose a framework to assess the value of pharmaceutical innovations, with explicit clinical and methodological parameters, based on the therapeutic value and health needs. RESEARCH DESIGN AND METHODS: The study was based on the adaptation of health technology assessment methods documented in the literature, which was applied to a sample of oncological drugs. Difficulties and issues during the application of those tools were identified and addressed to develop a new framework with new and revised domains and clear classification criterion for each domain. Scores were assigned to each level and domain according to their relevance to generate the final score of innovativeness. RESULTS: The Pharmaceutical Innovation Index (PII) includes four domains, two related to clinical and social dimensions - Therapeutic Need and Added Therapeutic Value - and other two about methodological features - Study Design and Quality (risk of bias). The scores combined after assigned to each domain results Index of the Innovativeness of the medicines represents the degree of pharmaceutical innovation. CONCLUSION: This work proposes a transparent methodology with well-defined criteria and script; the algorithm developed with authors' weightings and criteria may be switched to best adjust to other applications, perspective or clinical indications, while keeping the transparency and objectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalAntineoplastic AgentsResearch DesignAlgorithmsHumansNeoplasmsHealth Services Needs and DemandBias

Stichwörter der Autor:innen

Health technology assessmentadded therapeutic valueinnovativenesspharmaceutical innovationpharmaceuticalsvalue-based innovation

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Postgraduate Program in Medicines and Pharmaceutical Care (PPGMAF), Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Collaborating Centre for Health Technology Assessment and Excellence (CCATES), Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Förderung

  • Minas Gerais State Research Support Foundation

Zitieren

APA

Gargano, L. P., Alvares-Teodoro, J., de A Acurcio, F., & Guerra, A. A. (2024). Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2024.2365985

Vancouver

Gargano LP, Alvares-Teodoro J, de A Acurcio F, Guerra AA. Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs. Expert Review of Pharmacoeconomics & Outcomes Research. 2024. doi:10.1080/14737167.2024.2365985

BibTeX
@article{Gargano2024,
  author = {Gargano, Ludmila P and Alvares-Teodoro, Juliana and de A Acurcio, Francisco and Guerra, Augusto A},
  title = {Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2024},
  doi = {10.1080/14737167.2024.2365985}
}
Kostenlos starten →